From: Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders
Current medication | Â | ANX-DEP (n = 310) | MAN-FAT (n = 152) | DEV-PSY (n = 143) | Significance test |
---|---|---|---|---|---|
NIL | Count | 97 | 31 | 35 | χ2 (2, 605) = 6.6 [.037] |
% | 31.2% | 20.3% | 24.5% | ||
Any anti-depressant | Count | 158 | 71 | 38 | χ2 (2, 605) = 23.9 [.000] |
% | 50.8% | 46.7% | 26.6% | ||
Any anti-psychotic | Count | 68 | 74 | 87 | χ2 (2, 605) = 73.5 [.000] |
% | 21.9% | 48.7% | 60.8% | ||
Any mood stabilizer | Count | 19 | 49 | 12 | χ2 (2, 605) = 64.6 [.000] |
 | % | 6.1 | 32.2 | 8.4 |  |